Celldex Therapeutics Inc.

NASDAQ:CLDX 4:00:00 PM EDT

39.07

-0.18 (-0.46%)

5:10:48 PM EDT: $39.07 0.00 (0.00%)

Market Cap (Intraday)	2.52B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.81 Million
Adjusted EPS	-$0.69

See more estimates

10-Day MA	$39.88
50-Day MA	$41.87
200-Day MA	$34.23

See more pivots

Celldex Therapeutics Inc. Stock, NASDAQ:CLDX

Perryville III Building, 53 Frontage Road, Hampton, New Jersey 08827

United States of America

Phone: +1.908.454.7120

Number of Employees: 160

http://www.celldex.com

Description

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.